📰 Salubris Pharmaceuticals News
Salubris Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Salubris Pharmaceuticals. Real-time updates on events, politics, business and more.
November 2, 2022
Stroke patients with normal, but not those with impaired, renal function have greater benefit with ticagrelor-aspirin than clopidogrel-aspirin
November 2, 2022
Among CYP2C19 loss-of-function allele carriers with minor stroke or transient ischemic attack, those with normal renal function rather than impaired renal function derive greater benefit from ticagrelor-aspirin versus clopidogrel-aspirin.
October 30, 2022
Chicago-based VectorBuilder, a gene therapy delivery CDMO, raised $57 million in a Series C round from China investors.